Superior outcomes have been established with the use of an arteriovenous fistula (AVF) at first hemodialysis. However, considering the influence of comorbidities, medical insurance, and specialist care, racial/ethnic differences in the patterns of utilization of AVFs are unknown and deserve evaluation.
I n 2010, end-stage renal disease (ESRD) affected 593 086 persons in the United States, 383 992 of whom were treated with hemodialysis. 1 Arteriovenous fistulas (AVFs) confer a survival benefit relative to intravascular hemodialysis catheters (IHCs) in the incident hemodialysis population, a finding reported in multiplicity before and during the era of the fistula first-based initiative. [2] [3] [4] [5] The results of racially/ ethnically stratified studies [6] [7] [8] [9] suggest that minority patients tend to receive inferior incident hemodialysis access, either with arteriovenous grafts (AVGs) or IHCs. Minority patients have more comorbid diseases or socioeconomic challenges that limit their access to the health care system. 9 The concern about increased surgical risk results in higher incident hemodialysis with an IHC. A lack of medical insurance coverage delays permanent hemodialysis access placement until the final stages of ESRD, leaving too short of an interval to mature a fistula before starting hemodialysis. 7, 10 However, the actual demographic differences between white vs black vs Hispanic ESRD populations, as well as the effect of these differences on incident hemodialysis access, are unknown. Within the US Renal Data System (USRDS) database, this study evaluates national trends in incident hemodialysis access with respect to race/ethnicity (both overall and stratified by comorbid disease), receipt of nephrology care, and medical insurance status.
Methods

Study Design
A retrospective analysis of a prospectively maintained database was performed that examined all patients initiating renal replacement therapy between January 1, 2006, and December 31, 2010 , in the USRDS. The Johns Hopkins Medicine institutional review boards and the USRDS approved this study and waived the need for informed consent. All patients diagnosed as having ESRD in the United States are registered in the USRDS. Data entry required a physician, nurse, or social worker to complete the Centers for Medicare & Medicaid Services Form 2728 within 45 days after patients receive a kidney transplant or establish chronic dialysis, even if the patient died within this period. Forms were not submitted for patients with acute renal failure. General and medical demographics were collected, as well as medical insurance status, hemodialysis access type, nephrology care, and ESRD network. Patients were categorized as white, black, or Hispanic race/ethnicity as delineated on the Centers for Medicare & Medicaid Services Form 2728. Patients in the category of other race/ethnicity were excluded from the analysis. Also excluded were patients with hemodialysis access established before 2006, as well as patients who received a kidney transplant at any time (as determined from cross-referenced data from the United Network for Organ Sharing).
Statistical Analysis
The primary outcome of the study was incident hemodialysis access with an AVF vs AVG vs IHC. Statistical tests, including χ 2 test and analysis of variance, were performed, and logistic regression was used to calculate the odds of each racial/ ethnic group's receiving a particular hemodialysis access type. Propensity score matching was performed to evaluate hemodialysis access rates between patients of different races/ ethnicities who had comparable demographic and medical characteristics. First, the independent predictors of initiating hemodialysis with an AVF were determined. Thereafter, propensity scores were generated based on the predictive variables. Logistic regression of matched subgroups was performed, and the probabilities of initiating hemodialysis with the reference access type were calculated. All analyses were performed with statistical software (STATA, version 12.1; StataCorp LP). P < .05 was considered significant. Overall, black patients and Hispanic patients were younger than white patients (mean age, 58.8 vs 58.9 vs 67.0 years, respectively; P < .001) and were more frequently female (48.1% and 43.3% vs 41.4%, respectively; P < .001) ( Table 1) . White patients had significantly more comorbidities, including congestive heart failure, coronary artery disease, peripheral arterial disease, chronic obstructive pulmonary disease, and cancer (P < .001 for all). Black patients and Hispanic patients also had receipt of nephrology care less frequently than white patients (57.9% vs 54.0% vs 63.2%, respectively) and were uninsured more often than white patients (11.7% vs 14.1% vs 4.4%, respectively) (P < .001 for both).
Results
Overall Patient Characteristics
Race/Ethnicity and Incident Hemodialysis Access Type
When categorized by incident hemodialysis access type, white patients had a 22% greater chance of initiating hemodialysis with an AVF than black patients (odds ratio [OR], 1.22; 95% CI, 1.20-1.24) and a 32% greater chance of initiating hemodialysis with an AVF than Hispanic patients (OR, 1.32; 95% CI, 1.28-1.35). In contrast, black patients had 80% higher odds of having a functional AVG at first hemodialysis than white patients (OR, 1.80; 95% CI, 1.74-1.86) and 97% higher odds of having an AVG than Hispanic patients (OR, 1.97; 95% CI, 1.87-2.08). Hemodialysis initiation with an IHC was highest among Hispanic patients compared with white patients (OR, 1.29; 95% CI, 1.26-1.33).
A complete breakdown of patient demographics stratified by race/ethnicity and incident hemodialysis access type is summarized in Table 2 . Women initiated hemodialysis with an AVG more frequently across all studied groups. White patients initiating hemodialysis with an AVF were older than black patients or Hispanic patients initiating hemodialysis with both an IHC and AVG (P < .001 for all). Black patients and Hispanic patients demonstrated significantly lower rates of congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, and cancer than white patients within each of the 3 hemodialysis access groupings (P < .001 for all). Black patients and Hispanic patients initiating hemodialysis with an IHC or AVG exhibited higher frequencies of and more severe diabetes mellitus, hypertension, and drug abuse and alcohol abuse (P < .001 for all).
Propensity Score Analysis
The propensity score analyses summarized in Table 3 indicate that older age, higher body mass index, presence of hypertension, receipt of nephrology care, and medical insurance coverage were all significantly associated with the presence and use of a functioning AVF at incident hemodialysis (P < .001 for all). Female sex, congestive heart failure, peripheral arterial disease, chronic obstructive pulmonary disease, cancer, diabetes mellitus, alcohol abuse, and immobility were all significantly associated with lower odds of initiating hemodialysis with an AVF (P < .001 for all). Coronary artery disease, cerebrovascular disease, tobacco use, and drug abuse were not independent predictors of initiating hemodialysis with an AVF. The propensity score generated from the group of white patients initiating hemodialysis with an AVF was then applied to the combined AVG and IHC groups for white, black, and Hispanic patients to obtain the probabilities of initiating hemodialysis with an AVF within each racial/ethnic category. The probability that white patients from the combined AVG and IHC groups would initiate hemodialysis with an AVF was 0.163 compared with 0.151 for black patients and 0.143 for Hispanic patients (P < .001 for both).
Race/Ethnicity and Hemodialysis Access Type Stratified by Medical Insurance Status and Nephrology Care
Medicare was the most common medical insurance status across all hemodialysis access groupings regardless of race/ ethnicity (Table 2) . However, black patients and Hispanic patients initiating hemodialysis with any access modality were significantly more likely to have no medical insurance or Medicaid compared with white patients (P < .001). To compare similar groups, the racial/ethnic groups were stratified by medical insurance status (no insurance vs Medicaid vs Medicare vs private insurance). Regardless of medical insurance status, both black patients and Hispanic patients initiated hemodialysis with an AVF less frequently than white patients ( Figure 1A .84] for insured) persistently initiated hemodialysis with an AVF less frequently than white patients (P < .05 for all). Within the uninsured population, Hispanic patients also initiated hemodialysis with an AVF significantly less often than black patients (P < .001). Incident AVF use was similar between black patients and Hispanic patients who had Medicare (P = .92). Black patients initiated hemodialysis with an AVG more often than either white patients or Hispanic patients regardless of medical insurance status ( Figure 1B) .
The weighted impact of nephrology care on initiating hemodialysis with an AVF was at least 7 times higher than that of other variables. Within the stratum of patients who had no nephrology care, AVF use was higher among black patients (OR, 1.29; 95% CI, 1.18-1.40; P < .001) and Hispanic patients (OR, 1.13; 95% CI, 1.02-1.26; P = .02) compared with white patients (Figure 2A ). Arteriovenous fistula use was similar among the races/ethnicities within the category of patients who had ne- Figure 2B ).
Discussion
The use of an AVF for incident hemodialysis is well known to result in superior outcomes compared with an AVG or IHC.
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Previous findings suggest that minority populations may initiate hemodialysis with an AVF less frequently than white patients, presumably due to worsening disease status, comorbidities, or reduced access to medical care. 9 In this study, we demonstrated that race/ethnicity is significantly associated with patients' incident hemodialysis access modality in several ways. Overall, minority patients initiate dialysis with an AVG or IHC significantly more often than white patients. This observation is true despite the fact that black patients and Hispanic patients tend to be significantly younger and have fewer comorbidities (including coronary artery disease, chronic obstructive pulmonary disease, and cancer) than white patients. Current ESRD treatment strategies result in fewer functional AVFs for racial/ethnic minority patients receiving their first hemodialysis treatment compared white patients even when black patients and Hispanic patients receiving an AVG or IHC appear to be better surgical candidates. These differences persist despite statistical adjustment for demographic and comorbid characteristics. The racial/ethnic disparities in incident AVF access that we describe deserve elucidation. The high rates of catheter use despite national programs to reverse this trend is unacceptable. A recent publication by our group identifies a policy gap among other contributors to the persistent use of an AVG and IHC at initial hemodialysis. 11 However, inadequate policy, comorbidities, and medical insurance status do not account for the racial/ethnic disparities that we have shown. It is likely that clinical judgment informs surgeons when treating patients with ESRD because no unified algorithm exists to date to aid in selecting between hemodialysis access types. Black and Hispanic hemodialysis patients older than 40 years demonstrate better survival than white hemodialysis patients. 12, 13 Therefore, one argument for the more frequent use of an AVG or IHC in these groups may be that survival is better regardless of hemodialysis access type. However, minority populations are also less likely to receive kidney transplants than white patients, 12, 14 which makes the use of a permanent form of hemodialysis access that much more pertinent in these groups. It is possible that black patients and Hispanic patients with chronic kidney disease are simply progressing too quickly to ESRD 15 to make AVFs a viable initial hemodialysis access option. Fistulas generally take up to 6 to 12 weeks to mature. 16 Consistent with this notion, both black patients and Hispanic patients appear to be younger than white patients at the time of dialysis initiation. Certain comorbidities may also exert an influence on perceived operative risk or fistula maturation. Congestive heart failure, coronary artery disease, and peripheral arterial disease are well-known operative risk factors, with the latter 2 also impacting fistula maturation. 17 However, the prevalence of these conditions in our study was actually lower among minority patients than among white patients. Diabetes mellitus has been shown to be associated with higher rates of primary fistula patency loss, 18 and the prevalence of diabetes mellitus (particularly severe disease) was significantly higher in the black and Hispanic groups in our study. Medical insurance status has been consistently shown to contribute to disparities in hemodialysis access type. 9 Age effects associated with Medicare enrollment, the dominant medical insurance mode, likely contribute to some of the observed racial/ethnic variations in AVF use. The mean age in all subgroups for black patients and Hispanic patients within our study was younger than 65 years, whereas white patients tended to have a mean age older than 65 years, rendering them eligible fortunately, the use of Medicaid limits reimbursement for predialysis care, disincentivizing surgeons from establishing AVF access before a patient completes the prescribed 3-month period of dialysis required to establish an ESRD diagnosis and trigger related physician payments. 22 This protocol likely limits the feasibility of establishing mature AVFs in many cases. Although we similarly describe some variation in hemodialysis access type stratified by medical insurance status, minority patients within our cohort consistently initiated dialysis using non-AVF access regardless of medical insurance status.
In addition, disparities exist within specific medical insurance status subgroups. Within the uninsured population, Hispanic patients initiated hemodialysis with an IHC more frequently than both black patients and white patients. The persistence of disparities within groups with similar types of medical insurance suggests that there are social, cultural, or behavioral determinants of access to health care within these minority populations as stated by others. 23 Certainly, language barriers within the Hispanic population probably have a role because barriers to health care are consistently reported among racial/ethnic and linguistic minority patients. 24 Identification and understanding of these sociocultural and behavioral determinants provide room for further study. AVFs in 74% of black patients in whom they were attempted. These data suggest that adequate intraoperative vein assessment, use of venous dilation and a proximal location, and careful follow-up can lead to long-term AVF patency even in patients in whom preoperative imaging findings are discouraging. The ongoing Hemodialysis Fistula Maturation Study 27 may provide further insights into parameters associated with successfully maturing AVFs rather than resorting to AVGs, as will developments in the identification and triaging of high-risk patients with chronic kidney disease into a multidisciplinary ESRD care model. Our propensity score analysis showed that nephrology care is perhaps the most significant factor influencing hemodialysis initiation by an AVF. Management by a nephrologist increased the odds of a patients' beginning dialysis with an AVF more than 11-fold. Prior investigations have demonstrated a similar finding. 28 We found that black and Hispanic populations without nephrology care initiate hemodialysis with an AVF more often than white patients (Figure 2A ). The reverse occurred on receipt of nephrology care. It is alarming that AVF utilization decreases among black and Hispanic patients compared with white patients with increasing length of nephrology care. It can be argued that there is less receipt of nephrology care among minority patients. 9 However, the disparity persisted after stratified analyses, propensity score matching, and adjustment for demographic and medical characteristics. The situation raises critical questions about the possible social and cultural contributors to this occurrence and deserves an urgent system review, considering the vital role nephrologists have in improving hemodialysis initiation with an AVF. 29, 30 As a result, it is imperative that the American Medical Association, American College of Surgeons, National Kidney Foundation, and Centers for Medicare & Medicaid Services must identify and address the reasons why minority populations do not receive the well-known benefits of this multidisciplinary approach to the care of patients with ESRD with regard to AVF placement. The USRDS is a large database derived from the Centers for Medicare & Medicaid Services Form 2728, which is completed by a myriad of practitioners. Therefore, variability in diagnoses, patient demographics, and data completeness is expected. However, prior investigations have demonstrated reliability in diagnoses with the USRDS database. 31 We acknowledge a potential for racial/ethnic heterogeneity, particularly because these are self-reported characteristics and because overlap between the 3 study groups is possible. However, our sample size is large enough such that small inaccuracies should not significantly affect the overall results. In addition, regional variation in hemodialysis access creation has been reported, 28 ,32 which we have not considered in the present study. Furthermore, nephrologists and surgeons may preferentially select a particular hemodialysis access type for reasons that cannot be accounted for by a retrospective data set. It is not possible to adjust for all individual patient-based, system-based, and practice-based selection effects that may bias the USRDS data set. However, this preliminary description of racial/ethnic variations in incident hemodialysis access type can serve to initiate important conversations surrounding the presence of and potential reasons for racial/ethnic disparities in ESRD care and should raise interest in addressing areas that may be amenable to intervention with minority-based and similar initiatives in the future.
Conclusions
Black patients and Hispanic patients initiate dialysis using AVFs significantly less frequently than white patients despite their being younger and having fewer comorbidities. These disparities persisted independent of factors that drive health access for fistula placement, such as medical insurance status and nephology care. The sociocultural underpinnings of these disparities deserve investigation and redress to maximize the benefits of initiating hemodialysis via fistula in patients with ESRD irrespective of race/ethnicity.
